Aprepitant Capsules and Omadacycline Tosylate
Determining the interaction of Aprepitant Capsules and Omadacycline Tosylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Omalizumab
- Aprepitant Capsules-Omalizumab Subcutaneous
- Aprepitant Capsules-Ombitasvir, Paritaprevir, and Ritonavir
- Aprepitant Capsules-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Aprepitant Capsules-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Aprepitant Capsules-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Omadacycline Tosylate-Aprepitant Injection
- Omadacycline Tosylate-Aprepitant Intravenous
- Omadacycline Tosylate-Aprepitant Oral Suspension
- Omadacycline Tosylate-Aprepitant/Fosaprepitant Dimeglumine
- Omadacycline Tosylate-Apresazide
- Omadacycline Tosylate-Apresoline